Join the PSI Data Science SIG for Advancing Data Science in the Pharmaceutical Industry
The PSI Data Science SIG, established in 2017, comprises a group of Data Scientists and Statisticians focusing on various topics like Genomics, Machine Learning, and more. They aim to collaborate on data science in drug development, engage with regulatory bodies, and explore new data analysis methods. Join their upcoming meetings to contribute and stay updated on cutting-edge discussions.
Download Presentation
Please find below an Image/Link to download the presentation.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author. Download presentation by click this link. If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.
E N D
Presentation Transcript
Join the PSI Data Science SIG Start contributing and shaping the Data Science landscape in the Pharmaceutical Industry
Who we are? The PSI Data Science SIG was brought to life in 2017 We are a (small) group of Data Scientists and Statisticians with interests in a broad range of topics, including Genomics, RNA sequencing, predictive Biomarker evaluation, Pattern Recognition, Machine Learning (ML), Predictive Modeling and Explainable Artificial Intelligence (AI) Every 2ndWednesday, we meet on Teams to share and discuss mutual approaches. Everyone can propose topics for discussion or share challenges to get feedback and ideas. We also aim to shape the regulatory environment on Data Science! All Data Scientists and Statisticians who want to contribute are welcome to join our meetings: via this link. https://teams.microsoft.com/l/meetup-join/19%3a3d5a5a80b4a94e06b07d9b9afd31ba56%40thread.tacv2/1680811653461?context=%7b%22Tid%22%3a%22fcb2b37b-5da0-466b-9b83-0014b67a7c78%22%2c%22Oid%22%3a%22466ca6eb-f342-4df6-b77a-ad77e3b2fa68%22%7d
Our Mission Collaborate across industry on Data Science for Drug Development Increase awareness on Data Science tools and challenges Increase understanding and share experience with various types of data Interact with Regulatory Bodies on Data Science Discuss and exchange ideas on various methods, e.g. statistics, ML/AI, CS, and data-driven optimization for inference and prediction in various phases of R&D including diagnostics and operations Discuss and share analyses of new types of data: high frequency data from mobile devices, imaging data, unstructured data, (very) high dimensional data, and Real World Data (RWD) Promoting insights into new developments in software, programming languages, and handy tools Collaborate with other SIGs in areas of mutual interest
Upcoming Topics to Talk about FDA and ML/AI An overview about the FDA s recent discussion paper on ML/AI in the development of pharmaceutical therapies Principal Component Analysis et al. How to find patterns in data. Quantum Computing What they can do? How can we benefit in the Pharmaceutical Industry? Optimal Operational Design of Clinical Trials. Predicting Event counts in Event-Driven Trials [Oncology] And we are always looking for more hot topics so bring Yours along!
Upcoming Meetings Wednesday, 11th October, 10-11am BST Wednesday, 25th October , 10-11am BST Wednesday, 8th November , 10-11am BST Wednesday, 22nd November , 10-11am BST Wednesday, 6th December , 10-11am BST Meeting Link is HERE Please contact julia.chernova@bayer.com or julie.russell@bayer.com for being included into the Teams meeting
